Navigation Links
Charlie Rose Science Series Episode #10 - GLOBAL HEALTH October 29, 2007
Date:10/23/2007

Discussion on the Challenge of Researching and Implementing Affordable

Treatments for the World's Major Infectious Diseases

NEW YORK, Oct. 23 /PRNewswire/ --

WHAT: The upcoming episode of the Charlie Rose Science Series will

discuss the fundamental problems of health in the developing world

-- ranging from the AIDS crisis to malaria, tuberculosis, cholera,

dengue fever and other neglected diseases.

A group of experts will explore the challenge of researching and

implementing affordable treatments, as well as the physical,

political and psychological obstacles that poverty presents in

getting these therapies to the people who need them.

WHO: Guests will include:

-- Peter Hotez, MD, PhD, Professor and Chair, Department of

Microbiology, Immunology and Tropical Medicine at George

Washington University

-- Jeffrey Sachs, PhD, Director of The Earth Institute and

Professor of Health Policy and Management at Columbia University

-- Tonya Villafana, PhD, MPH, Director, Portfolio Management System

at the Malaria Vaccine Initiative

-- Ann M. Veneman, Executive Director of UNICEF

WHEN: Begins Airing on October 29, 2007 on PBS stations. Check your

local PBS listings for show times.

DESCRIPTION:

The Charlie Rose Science Series sponsored by Pfizer Inc is an exploration of modern advances in scientific research, their contribution to our understanding of the world around us, and how science breakthroughs can be applied to improving human health.

Charlie Rose is joined in this effort by his co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University.

As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com.

CONTACT: Rexy Legaspi (646) 213-7245


'/>"/>
SOURCE Pfizer Inc
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Science of swooning
2. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
3. The Science of Solar Eclipse
4. The Unpredictable Face Of Science
5. Science backs the importance of vegetables in diet
6. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
7. US Academy honors 15 for major contributions to science
8. East And West Meet Under The Aegis of NY Academy Of Sciences
9. Getting Basic Science to Work For Medicine
10. Sleep Science awakens from deep slumber!
11. Arab World Wakes Up To the Call of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company that ... product to the United States as part of its presence to expand its market ... aims to reduce the productions of nasty toxins as a result of drinking alcohol, ...
(Date:1/21/2017)... ... January 21, 2017 , ... Phytocéane invites you to take ... rest of the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, ... Coconut Oil and moisturizing vegetal coral to create this gentle, crystal-clear shower gel to ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... new medical office in Petaluma, located at 167 Lynch Creek Way. The Petaluma ... SRO sports medicine and rehabilitation services and on-site x-ray services. Two ...
(Date:1/20/2017)... ... ... Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift ... can be wheeled out of the way and stored when not in use. It is ... the feedback from customers into specific enhancements and created a new product that is built ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a ... percent pure essential oils, announced the company had a successful visit to the 2017 ... ECRM event gives companies that work in the nutritional, sports and health industries a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange ... excited to announce that the first five replication ...  (RP:CB) have been published in eLife today. Despite ... represents the first practical evaluation of reproducibility rates ... reproducible studies. Unlike other assessments of reproducibility, the ...
Breaking Medicine Technology: